The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
General Dynamics GD
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · General Dynamics Corporation operates as an aerospace and defense company worldwide.
read at $386.75
General Dynamics holds its Markup at $386.75.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 18 days |
| Price | $386.75 |
| Valuation | 24.35 trailing · 21.23 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.34 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $365.79 fair value estimate, narrow competitive moat, 10.30% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
| Revenue growth | 10.30% |
| Profit margin | 8.07% |
| Debt to equity | 37.70 |
| Analyst consensus | Buy · 21 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Aerospace & Defense Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Defense Giant Trips Over Its Own Ethics Line
Every time a navy orders another submarine or a business buys a new jet, General Dynamics stands ready with the hardware. Yet we pass, for two clear reasons that have nothing to do with the quality of the work. The shares trade at our fair value with a margin of safety near zero, and the business fails our ethical screen outright.
Revenue is growing at 10 percent with an 8 percent profit margin and an 18 percent return on equity, but the forward multiple of 20 times earnings looks full for a narrow-moat contractor. Analysts like the name and see upside, yet none of that moves the ethical verdict.
Risk centres on sudden shifts in defence budgets and the narrow edge that leaves little pricing power when contracts tighten. This is exactly what the screen is for. Analysis, not advice.
| Forward P/E | 21.2x expensive even after accounting for its growth |
| Trailing P/E | 24.4x a premium valuation |
| Revenue growth | 10.3% steady growth |
| Profit margin | 8.1% thin but positive margins |
| Return on equity | 18.0% a solid return on shareholder capital |
| Debt to equity | 0.38 minimal debt — a conservative balance sheet |
| Current ratio | 1.38 adequate liquidity, worth monitoring |
| Beta | 0.34 barely tracks the market's swings |
| Market cap | $104.6B |
| Employees | 110,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on GD
- › Is GD Expanding Its Presence in the Armored Vehicle Market? Zacks · 15d ago
- › Trump Just Gave a Shoutout to This Top Defense Contractor. Here’s What to Know. Barchart · 15d ago
- › More than 30 companies commit $10B to Pennsylvania defense industry Manufacturing Dive · 15d ago
- › Trump Presses General Dynamics as $1.5 Trillion Defense Budget Advances GuruFocus.com · 16d ago
- › Northrop Grumman to Post Q2 Earnings: Here's What to Expect Zacks · 16d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in GD's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
GD trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it buy, with a mean price target of $392. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | BURNS MARK LAGRAND | Officer | 72,710 | $25,040,695 | |
| 2026-05-12 | BURNS MARK LAGRAND | Officer | 72,710 | $12,144,047 | |
| 2026-03-17 | DE LEON RUDY F | Director | 52 | $18,424 | |
| 2026-03-17 | REYNOLDS CATHERINE B | Director | 105 | $37,203 | |
| 2026-03-17 | SCHUMACHER LAURA J | Director | 105 | $37,203 | |
| 2026-03-17 | HOOPER CHARLES W. | Director | 21 | $7,441 | |
| 2026-03-17 | HANEY CECIL D. | Director | 10 | $3,543 | |
| 2026-03-17 | STRATTON JOHN G. | Director | 105 | $37,203 | |
| 2026-03-17 | NYE C HOWARD | Director | 52 | $18,424 | |
| 2026-03-17 | MATTIS JAMES N | Director | 105 | $37,203 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2025-01-15 | Mark Green | buy | 15000 | |
| 16 Jun2026 | Gil Cisneros | Democrat | sell | 1K–15K |
| 10 Jun2026 | Dwight Evans | Democrat | sell | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $344.03 | -0.4% | · | $996 | -0.4% |
| 2 months | $335.15 | +2.2% | · | $1,022 | +2.2% |
| 3 months | $353.59 | -3.1% | $1.59 | $973 | -2.7% |
| 6 months | $338.52 | +1.2% | $3.09 | $1,021 | +2.1% |
| 1 year | $272.36 | +25.8% | $6.09 | $1,280 | +28.0% |
| 2 years | $283.45 | +20.9% | $11.85 | $1,250 | +25.0% |
| 3 years | $199.66 | +71.6% | $17.23 | $1,802 | +80.2% |
| 5 years | $172.08 | +99.1% | $27.16 | $2,149 | +114.9% |
Historical returns from market close data. Past performance does not guarantee future results.